Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation

NCT03021928 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT03021928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03021928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
Lead sponsor
University of Texas at Austin
Phase
Phase 3
Overall status
Unknown status
Start date
June 14, 2017
Completion date
December 31, 2023
Enrollment
200 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

stroke